In a landmark medical achievement, SIMS Hospitals successfully performed India’s first endoscopic keyhole removal of a left ventricular cardiac tumour, marking a breakthrough in minimally invasive heart surgery. The tumour, located in the heart’s main pumping chamber, was removed without the need for a sternotomy — an open-chest procedure traditionally used for such conditions. The patient, a 45-year-old woman, was found to have a 1.6 × 1.5 cm mass inside the left ventricle, which was confirmed after doctors performed a cardiac MRI. Primary cardiac tumours account for just 0.6 per cent of cardiac surgeries in India, and left ventricular tumours are even rarer, occurring in approximately one in 20–30 million people. The cardiac team from the Chennai-based
hospital opted for an endoscopic, minimally invasive approach, accessing the heart through small openings between the ribs. This technique eliminates the need to cut through the chest bone, significantly reducing pain, blood loss, hospital stay, and visible scarring. Doctors said the tumour was successfully excised under endoscopic vision, eliminating the risk of stroke and restoring normal heart function. “This success reflects the strength of our clinical ecosystem and endoscopic capabilities,” said Dr Ravi Pachamuthu, Chairman, SIMS Hospital. “The team has set a new benchmark in cardiac care,” he added. Doctors said such procedures are exceptionally rare even globally, making this a first-of-its-kind achievement in India. The patient was supported using a heart-lung machine introduced via the right groin, and the tumour was excised through a 3 cm incision in the right chest. She recovered smoothly and resumed normal activities within two weeks. Highlighting the benefits of the techniques, Dr. Mohammed Ibrahim, Consultant – Cardiothoracic Surgery, said that minimally invasive cardiac surgery drastically reduces pain, recovery time, and scarring. The team has already performed five similar procedures with 100 per cent success, and continues to use keyhole approaches for coronary artery disease, valvular disorders, septal defects, and mediastinal tumours.






/images/ppid_59c68470-image-176535005559269989.webp)




